Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
ORAL CONTROLLED RELEASE COMPOSITIONS COMPRISING VITAMIN D COMPOUND AND WAXY CARRIER

No-Receipt date 2013-00608 - 26/02/2013
No-Filing date 20130400424 - 26/02/2013
No-Granting date 3080221 - 28/02/2013
No-EPO application date 08746908.6 - 25/04/2008
No-EPO granting date 2148661 - 12/12/2012
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 2/2013 - 27/03/2013
Expiration date 26/04/2028
Kind of title Validation of European Patent
Legal status VALID
Priorities US913853 P25/04/2007/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/593
A61K 47/06
A61K 47/14
A61K 47/44
A61K 9/48

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
695864 OPKO IRELAND GLOBAL HOLDINGS, LTD. CITYWEST BUSINESS CAMPUS, 3013 LAKE DRIVEDUBLIN 24, IRELAND IRELAND
692685 OPKO RENAL, LLC 4400 BISCAYNE BOULEVARDMIAMI, FL 33137, U.S.A. UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
1090071 TABASH, SAMIR, P.
1090072 WHITE, JAY, A.
1090073 BISHOP, CHARLES, W.

Representatives
CodeFirstnameSurnameAddressTownZip
25MARIAATHANASIADOUKOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
848EFANGELIAGIAZITZOGLOU - THOMAIDOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History
Date Description Comments Data before modification Data after modification
16/05/2019 Μεταβίβαση (7e802) Α.Π.4200-Η.Θ.76772/24-4-19, ΔΝΥ.735, ΚΩΔ.ΠΛΗΡ.3458 457408 Cytochroma Inc. 100 Allstate Parkway, Suite 600 ΚΑΝΑΔΑΣ Markham, ON L3R 6H3
16/05/2019 Μεταβίβαση (7e802) Α.Π.4200-Η.Θ.76772/24-4-19, ΔΝΥ.735, ΚΩΔ.ΠΛΗΡ.3458 1058133 Cytochroma Cayman Islands Ltd c/o Maples Corporate Services, PO Box 309 Ugland House ΝΗΣΟΙ ΚΑΫΜΑΝ KY1-1104, Grand Kayman, CAYMAN ISLANDS
16/05/2019 Μεταβίβαση (7e802) Α.Π.4203-Η.Θ.76761/24-4-19, ΔΝΥ.835, ΚΩΔ.ΠΛΗΡ.3458 457409 Proventiv Therapeutics, LLC 2333 Waukegan Road Suite E100 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Bannockburn, IL 60015
16/05/2019 Μεταβίβαση (7e802) Α.Π.4203-Η.Θ.76761/24-4-19, ΔΝΥ.835, ΚΩΔ.ΠΛΗΡ.3458 457409 Proventiv Therapeutics, LLC 2333 Waukegan Road Suite E100 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Bannockburn, IL 60015
16/05/2019 Μεταβίβαση (7e802) Α.Π.4201-Η.Θ.76768/24-4-19, ΔΝΥ.735, ΚΩΔ.ΠΛΗΡ.3458 457409 Proventiv Therapeutics, LLC 2333 Waukegan Road Suite E100 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Bannockburn, IL 60015
16/05/2019 Μεταβίβαση (7e802) Α.Π.4201-Η.Θ.76768/24-4-19, ΔΝΥ.735, ΚΩΔ.ΠΛΗΡ.3458 457409 Proventiv Therapeutics, LLC 2333 Waukegan Road Suite E100 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Bannockburn, IL 60015
16/05/2019 Μεταβίβαση (7e802) Α.Π.4202-Η.Θ.76763/24-4-19, ΔΝΥ.735, ΚΩΔ.ΠΛΗΡ.3458 457409 Proventiv Therapeutics, LLC 2333 Waukegan Road Suite E100 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Bannockburn, IL 60015
16/05/2019 Μεταβίβαση (7e802) Α.Π.4202-Η.Θ.76763/24-4-19, ΔΝΥ.735, ΚΩΔ.ΠΛΗΡ.3458 385963 OPKO Health, Inc. . ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Miami, FL 33137, U.S.A.
16/05/2019 Μεταβίβαση (7e802) Α.Π.4204-Η.Θ.76753/24-4-19, ΔΝΥ.735, ΚΩΔ.ΠΛΗΡ.3458 385963 OPKO Health, Inc. . ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Miami, FL 33137, U.S.A.
16/05/2019 Μεταβίβαση (7e802) Α.Π.4204-Η.Θ.76753/24-4-19, ΔΝΥ.735, ΚΩΔ.ΠΛΗΡ.3458 692685 OPKO Renal, LLC 4400 Biscayne Boulevard ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Miami, FL 33137, U.S.A.

Title Instruments
DateOperationDescreption
7/6/2023 12:00:00 AMΔιάφορες Μεταβολές (70004) ΑΡ.ΠΡΩΤ. 4430/10-02-2023 (ΛΙΣΤΑ) (ΑΡ.ΥΠΟΘ. 4654017/10-02-2023) ΔΝΥ. 440 ΚΩΔ.ΠΛΗΡ. 3464 ΑΡΣΗ & ΑΝΤΙΚΑΤΑΣΤΑΣΗ ΑΝΤΙΚΛΗΤΟΥ

Payments history 18 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).